Cargando…
Total parenteral nutrition-associated cholestasis and risk factors in preterm infants
BACKGROUND/AIM: Development of hepatic dysfunction is a well-recognized complication of total parenteral nutrition in preterm infants. Previous studies reported the incidence of total parenteral nutrition–associated cholestasis and described possible contributing factors to its pathogenesis, but lit...
Autores principales: | Alkharfy, Turki M., Ba-Abbad, Rubana, Hadi, Anjum, Sobaih, Badr H., AlFaleh, Khalid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196344/ https://www.ncbi.nlm.nih.gov/pubmed/25253364 http://dx.doi.org/10.4103/1319-3767.141688 |
Ejemplares similares
-
Mdr3 gene mutation in preterm infants with parenteral nutrition‐associated cholestasis
por: Yang, Xiufang, et al.
Publicado: (2022) -
High-Dose Oral Erythromycin Decreased the Incidence of Parenteral Nutrition-Associated Cholestasis in Preterm Infants
por: Ng, Pak C., et al.
Publicado: (2007) -
Parenteral nutrition with fish oil-based lipid emulsion reduces the risk of cholestasis in preterm infants
por: Wang, Yi-Ling, et al.
Publicado: (2021) -
Parenteral nutrition associated cholestasis
por: Costa, Simonetta, et al.
Publicado: (2015) -
Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study
por: Wang, Ya-sen, et al.
Publicado: (2023)